Skip to main content
Publications
Dominguez A, Dadvand P, Cirach M, Arevalo G, Barril L, Foraster M, Gascon M, Raimbault B, Galmes T, Gomez-Herrera L, Persavento C, Samuelsson K, Lao J, Moreno T, Querol X, Jerrett M, Schwartz J, Tonne C, Nieuwenhuijsen MJ, Sunyer J, Basagana X, Rivas I. Development of land use regression, dispersion, and hybrid models for prediction of outdoor air pollution exposure in Barcelona. Sci Total Environ. 2024 Dec 1;954:176632. doi: 10.1016/j.scitotenv.2024.176632
Filippini T, Rothman KJ, Cocchio S, Narne E, Mantoan D, Saia M, Goffi A, Ferrari F, Maffeis G, Orsini N, Baldo V, Vinceti M. Associations between mortality from COVID-19 in two Italian regions and outdoor air pollution as assessed through tropospheric nitrogen dioxide. Sci Total Environ. 2021 Mar 15;760:143355. doi: 10.1016/j.scitotenv.2020.143355
Osorio-Yanez C, Clemente DBP, Maitre L, Vives-Usano M, Bustamante M, Martinez D, Casas M, Alexander J, Thomsen C, Chatzi L, Gutzkow KB, Grazuleviciene R, Martens DS, Plusquin M, Slama R, McEachan RC, Wright J, Yang TC, Urquiza J, Tamayo I, Sunyer J, Vafeiadi M, Nawrot TS, Vrijheid M. Early life tobacco exposure and children's telomere length: the HELIX project. Sci Total Environ. 2020 Apr;711:135028. doi: 10.1016/j.scitotenv.2019.135028
Cechova E, Scheringer M, Seifertova M, Mikes O, Kroupova K, Kuta J, Forns J, Eggesbo M, Quaak I, de Cock M, van de Bor M, Patayova H, Palkovicova Murinova L, Kocan A. Developmental neurotoxicants in human milk: comparison of levels and intakes in three European countries. Sci Total Environ. 2017 Feb 1;579:637-45. doi: 10.1016/j.scitotenv.2016.11.046
Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, Lenzi R, Chajut A, Edmonston TB, Raber MN. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary. Clin Cancer Res. 2011 Jun 15;17(12):4063-70. doi: 10.1158/1078-0432.CCR-10-2599
LoRusso PM, Herbst RS, Rischin D, Ranson M, Calvert H, Raymond E, Kieback D, Kaye S, Gianni L, Harris A, Bjork T, Maddox A, Rothenberg ML, Small EJ, Rubin EH, Feyereislova A, Heyes A, Averbuch SD, Ochs J, Baselga J. Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors. Clin Cancer Res. 2003 Jun 1;9(6):2040-8.